Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-000488

Director acquired 2,533 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anderson Raymond · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-31 Exercise or conversion : show line 1 in the form +2,533 26,863 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-31 Exercise or conversion : show line 2 in the form Restricted Stock Units −2,533 0 D
Loading xslF345X05/rdgdoc.xml…